Myeloid Sarcoma with Megakaryoblastic Differentiation Arising in the Conjunctiva

被引:4
作者
Jakobiec, Frederick A. [1 ]
Wolkow, Natalie [1 ]
Zakka, Fouad R. [2 ]
Rubin, Peter A. D. [3 ]
机构
[1] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, David G Cogan Lab Ophthalm Pathol, Boston, MA USA
[2] Brown Univ, Dept Pathol & Lab Med, Alpert Med Sch, Providence, RI 02912 USA
[3] Eyelid Experts, Palm Beach Gardens, FL USA
关键词
Myeloid sarcoma; Granulocytic sarcoma; Chloroma; Acute megakaryoblastic leukemia; Conjunctiva; Blast; Megakaryocyte; Myelofibrosis; JAK2; V617F mutation; Trisomy; 8; t(12; 17) translocation; GRANULOCYTIC SARCOMA; MEGAKARYOCYTIC LEUKEMIA; MANIFESTATIONS; CHLOROMA; CHILDREN;
D O I
10.1159/000488057
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
An 87-year-old woman not known to have either a lymphoma or leukemia developed a left multinodular, fish-flesh superior epibulbar and forniceal mass. A biopsy disclosed a blastic tumor with scattered multinucleated immature megakaryoblasts. Immunophenotyping of bone marrow cells revealed strong positivity for CD7, CD31, CD43, CD45, CD61, and CD117; CD71, myeloperoxidase, and lysozyme were also positive in scattered cells. Forty percent of the neoplastic cells were Ki-67 positive. Cytogenetic studies indicated a trisomy 8 (associated with worse prognosis) and a t(12;17) translocation. Desmin, smooth muscle actin, pancytokeratin, CAM 5.2, adipophilin, tryptase, S100, SOX10, MART1, and E-cadherin were negative, ruling out a nonhematopoietic tumor. The conjunctival lesion was diagnosed as a myeloid sarcoma with megakaryoblastic differentiation, a rare variant. It probably arose from a myelodysplastic syndrome. This is the first case of its type to develop in the conjunctiva. (C) 2018 S. Karger AG, Basel
引用
收藏
页码:28 / 35
页数:8
相关论文
共 38 条
  • [1] Orbital extra-medullary granulocytic sarcoma: clinicopathologic correlation with immunohistochemical features
    Aggarwal, Ekta
    Mulay, Kaustubh
    Honavar, Santosh G.
    [J]. SURVEY OF OPHTHALMOLOGY, 2014, 59 (02) : 232 - 235
  • [2] Arber D.A., 2017, HEMATOPATHOLOGY, P842
  • [3] Myeloid sarcoma: current approach and therapeutic options
    Avni, Batia
    Koren-Michowitz, Maya
    [J]. THERAPEUTIC ADVANCES IN HEMATOLOGY, 2011, 2 (05) : 309 - 316
  • [4] Bhargava R, 2014, DIAGNOSTIC IMMUNOHIS, P224
  • [5] Pan Myeloid Antigen-Negative Pediatric Acute Megakaryoblastic Leukemia
    Cetin, Neslihan
    Lorsbach, Robert B.
    [J]. PEDIATRIC BLOOD & CANCER, 2014, 61 (11) : 2089 - 2091
  • [6] Coffin C, 2014, DIAGNOSTIC IMMUNOHIS, P862
  • [7] Anterior chamber infiltrate in 3-month-old: rare presentation of myeloid sarcoma
    Dunbar, K. E.
    Hubbard, G. B., III
    Wells, J. R.
    [J]. EYE, 2012, 26 (09) : 1274 - 1275
  • [8] Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas
    Falini, B.
    Lenze, D.
    Hasserjian, R.
    Coupland, S.
    Jaehne, D.
    Soupir, C.
    Liso, A.
    Martelli, M. P.
    Bolli, N.
    Bacci, F.
    Pettirossi, V.
    Santucci, A.
    Martelli, M. F.
    Pileri, S.
    Stein, H.
    [J]. LEUKEMIA, 2007, 21 (07) : 1566 - 1570
  • [9] Hasserjian RP., 2017, HEMATOPATHOLOGY, P793
  • [10] Hyjek E, 2017, HEMATOPATHOLOGY, P883